BAX
Baxter International IncNYSEHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$8.81B
P/E Ratio
—
EPS
$-1.75
Beta
0.55
52W High
$34.05
52W Low
$16.08
50-Day MA
$19.46
200-Day MA
$22.39
Dividend Yield
3.11%
Profit Margin
-8.51%
Forward P/E
8.50
PEG Ratio
36.68
About Baxter International Inc
Baxter International Inc. is an American multinational health care company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat hemophilia, kidney disease, immune disorders and other chronic and acute medical conditions.
Fundamentals
| Revenue (TTM) | $11.24B |
| Gross Profit (TTM) | $4.02B |
| EBITDA | $2.02B |
| Operating Margin | 7.36% |
| Return on Equity | -13.70% |
| Return on Assets | 2.83% |
| Revenue/Share (TTM) | $21.92 |
| Book Value | $11.92 |
| Price-to-Book | 1.36 |
| Price-to-Sales (TTM) | 0.78 |
| EV/Revenue | 1.434 |
| EV/EBITDA | 21.05 |
| Quarterly Earnings Growth (YoY) | 237.90% |
| Quarterly Revenue Growth (YoY) | 8.00% |
| Shares Outstanding | $514.49M |
| Float | $512.23M |
| % Insiders | 0.30% |
| % Institutions | 109.61% |
Historical Volatility
HV 10-Day
41.55%
HV 20-Day
40.24%
HV 30-Day
67.60%
HV 60-Day
53.69%
HV Rank
85.7%
Volatility is currently contracting
Analyst Ratings
Consensus ($21.96 target)
1
Strong Buy2
Buy13
Hold1
SellData last updated: 3/26/2026